Ananda Pharma (1FX GR)

Ananda Pharma is a biopharmaceutical company focused on developing and commercializing cannabinoid-based therapies. It specializes in creating regulatory-approved medicines for complex, chronic inflammatory pain conditions such as endometriosis and chemotherapy-induced peripheral neuropathy, as well as drug-resistant epilepsies. The company was incorporated in 2018 and is based in London, United Kingdom.